C. Rafie

Distinct Mechanisms of Innate and Adaptive Immune Regulation Underlie Poor Oncologic Outcomes Associated with KRAS-TP53 Co-Alteration in Pancreatic Cancer

A. Colaprico, N. Merchant, Xiaodian Sun, 2022, bioRxiv.

Lost In Translation: The Scientist’s Perspective In Navigating From Pipetto Patient

C. Rafie, Christine I Rafie, 2017 .

Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide

E. Jaffee, A. Popel, V. Stearns, 2020, Oncoimmunology.

Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs

E. Jaffee, Alexander C. Hopkins, Nilofer Azad, 2018, Cancer Immunology Research.

Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)

Chenguang Wang, E. Jaffee, A. Cimino-Mathews, 2021, Clinical Cancer Research.

Phenotypic shifts of tumor associated macrophages and STAT3 mediated suppression of myeloid derived suppressor cells drive sensitization of HER2+ tumor immunity

Daria A. Gaykalova, E. Jaffee, E. Fertig, 2021, bioRxiv.